140 related articles for article (PubMed ID: 33191092)
1. Orbital exenteration: A 20-year experience from a tertiary center in Taiwan.
Wang WY; Liao SL; Wei YH
J Formos Med Assoc; 2021 Jul; 120(7):1493-1499. PubMed ID: 33191092
[TBL] [Abstract][Full Text] [Related]
2. Orbital exenteration for advanced periorbital non-melanoma skin cancer: prognostic factors and survival.
Gerring RC; Ott CT; Curry JM; Sargi ZB; Wester ST
Eye (Lond); 2017 Mar; 31(3):379-388. PubMed ID: 27768120
[TBL] [Abstract][Full Text] [Related]
3. Orbital exenteration: The 10-year Massachusetts Eye and Ear Infirmary experience.
Nagendran ST; Lee NG; Fay A; Lefebvre DR; Sutula FC; Freitag SK
Orbit; 2016 Aug; 35(4):199-206. PubMed ID: 27322708
[TBL] [Abstract][Full Text] [Related]
4. Orbital exenteration: Institutional review of evolving trends in indications and rehabilitation techniques.
Kiratli H; Koç İ
Orbit; 2018 Jun; 37(3):179-186. PubMed ID: 29039986
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological profile of orbital exenteration: 14 years of experience from a tertiary eye care center in South India.
Ali MJ; Pujari A; Dave TV; Kaliki S; Naik MN
Int Ophthalmol; 2016 Apr; 36(2):253-8. PubMed ID: 26249131
[TBL] [Abstract][Full Text] [Related]
6. Orbital exenteration and conjunctival melanoma: a 14-year study at the Jules Gonin Eye Hospital.
Martel A; Oberic A; Moulin A; Zografos L; Bellini L; Almairac F; Hamedani M
Eye (Lond); 2020 Oct; 34(10):1897-1902. PubMed ID: 31959885
[TBL] [Abstract][Full Text] [Related]
7. Rapid Rehabilitation With Skin-Muscle Sparing Orbital Exenteration: A Single-Center Series.
Jayaprakasam A; Vahdani K; Rose GE; Saleh GM; Hussain B; Verity DH; Collin JRO
Ophthalmic Plast Reconstr Surg; 2021 Jan-Feb 01; 37(1):51-54. PubMed ID: 32379171
[TBL] [Abstract][Full Text] [Related]
8. Orbital exenteration: a 13 year Manchester experience.
Rahman I; Cook AE; Leatherbarrow B
Br J Ophthalmol; 2005 Oct; 89(10):1335-40. PubMed ID: 16170127
[TBL] [Abstract][Full Text] [Related]
9. Orbital Exenteration for Advanced Periocular Adnexal Malignancies: Curative Versus Palliative Surgical Intent.
Malik M; Vahdani K; Rose GE; Daniel C; Uddin JM; Verity DH; Collin JRO
Ophthalmic Plast Reconstr Surg; 2022 Jul-Aug 01; 38(4):387-392. PubMed ID: 35093991
[TBL] [Abstract][Full Text] [Related]
10. Orbital exenteration: one size does not fit all.
Ben Simon GJ; Schwarcz RM; Douglas R; Fiaschetti D; McCann JD; Goldberg RA
Am J Ophthalmol; 2005 Jan; 139(1):11-7. PubMed ID: 15652823
[TBL] [Abstract][Full Text] [Related]
11. Clinical features predictive of orbital exenteration for conjunctival melanoma.
Shields JA; Shields CL; Gündüz K; Cater J
Ophthalmic Plast Reconstr Surg; 2000 May; 16(3):173-8. PubMed ID: 10826757
[TBL] [Abstract][Full Text] [Related]
12. Orbital exenteration: Symptoms, indications, tumour localizations, pathologies, reconstruction, complications and survival.
Baum SH; Schmeling C; Eckstein A; Mohr C
J Craniomaxillofac Surg; 2021 Aug; 49(8):659-669. PubMed ID: 33992516
[TBL] [Abstract][Full Text] [Related]
13. Mortality following exenteration for malignant tumours of the orbit.
Rahman I; Maino A; Cook AE; Leatherbarrow B
Br J Ophthalmol; 2005 Nov; 89(11):1445-8. PubMed ID: 16234450
[TBL] [Abstract][Full Text] [Related]
14. Pattern of orbital exenteration in a tertiary eye care centre in India.
Pushker N; Kashyap S; Balasubramanya R; Bajaj MS; Sen S; Betharia SM; Ghose S
Clin Exp Ophthalmol; 2004 Feb; 32(1):51-4. PubMed ID: 14746592
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of orbital exenteration for craniofacial lesions.
Traylor JI; Christiano LD; Esmaeli B; Hanasono MM; Yu P; Suki D; Zhang W; Raza SM; Hanna EY; DeMonte F
Cancer; 2021 Jul; 127(14):2465-2475. PubMed ID: 33799313
[TBL] [Abstract][Full Text] [Related]
16. Experience with eyelid-sparing orbital exenteration: the 2000 Tullos O. Coston Lecture.
Shields JA; Shields CL; Demirci H; Honavar SG; Singh AD
Ophthalmic Plast Reconstr Surg; 2001 Sep; 17(5):355-61. PubMed ID: 11642492
[TBL] [Abstract][Full Text] [Related]
17. Secondary orbital exenteration for conjunctival melanoma: A study of 25 cases.
Lemaître S; Lévy-Gabriel C; Dendale R; Vincent-Salomon A; Lumbroso-Le Rouic L; Cassoux N; Couturaud B; Desjardins L
J Fr Ophtalmol; 2021 Mar; 44(3):415-419. PubMed ID: 33573797
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for orbital exenteration in periocular Basal cell carcinoma.
Iuliano A; Strianese D; Uccello G; Diplomatico A; Tebaldi S; Bonavolontà G
Am J Ophthalmol; 2012 Feb; 153(2):238-241.e1. PubMed ID: 21982108
[TBL] [Abstract][Full Text] [Related]
19. Orbital Exenteration: A 23-year Report.
Kasaee A; Eshraghi B; Nekoozadeh S; Ameli K; Sadeghi M; Jamshidian-Tehrani M
Korean J Ophthalmol; 2019 Aug; 33(4):366-370. PubMed ID: 31389213
[TBL] [Abstract][Full Text] [Related]
20. Orbital Exenteration to Manage Infiltrative Sinonasal, Orbital Adnexal, and Cutaneous Malignancies Provides Acceptable Survival Outcomes: An Institutional Review, Literature Review, and Meta-Analysis.
Hoffman GR; Jefferson ND; Reid CB; Eisenberg RL
J Oral Maxillofac Surg; 2016 Mar; 74(3):631-43. PubMed ID: 26475973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
